Current morphological diagnosis of malignant lung tumors;Aktuelle morphologische diagnostik bösartiger lungentumoren

Pathologe

Volumn 27, Issue 2, 2006, Pages 90-98

  Junker, K ^a  

^a KLINIKUM BREMEN MITTE   (Germany)

Author keywords

EGFR; Gene expression profiling; Lung cancer; Neuroendocrine neoplasms; WHO classification

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR;

ADENOCARCINOMA; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER GRADING; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CARCINOMA; DISEASE SEVERITY; DRUG TARGETING; GENE EXPRESSION PROFILING; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MOLECULAR DYNAMICS; MORPHOLOGY; PROGNOSIS; REVIEW; WORLD HEALTH ORGANIZATION;

CARCINOMA, NON-SMALL-CELL LUNG; GENE EXPRESSION PROFILING; HUMANS; LUNG; LUNG NEOPLASMS; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 33644781950     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-006-0818-1     Document Type: Review

References (25)

1. Berufsverband Deutscher Pathologen, Deutsche Gesellschaft für Pathologie (2005) Empfehlungen zur pathologisch-anatomischen Diagnostik von Lungentumoren
2. Colby TV, Koss MN, Travis WD (1995) Atlas of tumor pathology; tumors of the lower respiratory tract. AFIP, New York
3. Corrin B (2000) Pathology of the lungs. Churchill Livingstone, London
4. Garber ME, Troyanskaya OG, Schluens K et al. (2001) Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci USA 98:13784-13789
5. Giordano TJ, Shedden KA, Schwartz DR et al. (2001) Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles. Am J Pathol 159:1231-1238
6. Hatcher J, Dover DC (2003) Trends in histopathology of lung cancer in Alberta. Can J Public Health 94:292-296
7. Hirsch FR, Varella-Garcia M, Bunn PA Jr et al. (2003) Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J Clin Oncol 20:3798-3807
8. Janssen-Heijnen ML, Coebergh JW (2003) The changing epidemiology of lung cancer in Europe. Lung Cancer 41:245-258
9. Junker K (2004) Therapieinduzierte morphologische Veränderungen bösartiger Lungentumoren. Pathologe 25:475-480
10. Junker K, Wiethege T, Müller KM (2000) Pathology of small cell lung cancer. J Cancer Res Clin Oncol 126:361-368
11. Kikuchi K, Daigo Y, Katagiri T et al. (2003) Expression profiles of non-small cell lung cancers on cDNA mircoarrays: idenfitication of genes for prediction of lymph-node metastasis and sensitivity to anticancer drugs. Oncogene 22:2192-2205
12. Leslie KO, Wick MR (2005) Practical pulmonary pathology - a diagnostic approach. Churchill Livingstone, Philadelphia Edinburgh London New York Oxford St. Louis Sydney Toronto
13. Lynch TJ, Bell DW, Sordella R et al. (2004) Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to Gefitinib. N Engl J Med 350:1-11
14. Müller KM, Wiethege T (2005) Lungentumoren. Molekulare Pathologie und Prognosefaktoren. Onkologe 11:S12-S15
15. Müller KM, Wiethege T, Krismann M, Junker K (2002) Molekulare Pathologie bösartiger pulmonalerund pleuraler Tumoren - Teil 1: Pulmonale Tumoren. In: Ruckpaul D, Ganten D (Hrsg) Handbuch der molekularen Medizin, Bd 10. Springer, Berlin Heidelberg New York Tokyo, S 29-64
16. Nacht M, Dracheva T, Gao Y et al. (2001) Molecular characteristics of non-small cell lung cancer. Proc Natl Acad Sci USA 98:15203-15208
17. Oyama T, Osaki T, Baba T et al. (2005) Molecular genetic tumor markers in non-small cell lung cancer. Anticancer Res 25:1193-1196
18. Paez JG, Janne PA, Lee JC et al. (2004) EGFR mutations in lung cancer: correlation with clinical response to Gefitinib therapy. Science 304:1497-1500
19. Petty RD, Nicolson MC, Kerr KM et al. (2004) Gene expression profiling in non-small cell lung cancer: from molecular mechanisms to clincal application. Clin Cancer Res 10:3237-3248
20. Tomida S, Koshikawa K, Yatabe Y et al. (2004) Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients. Oncogene 23:5360-5370
21. Tsao MS, Sakurada A, Cutz JC et al. (2005) Erlotinib in lung cancer - molecular and clinical predictors of outcome. N Engl J Med 35:133-144
22. Wittekind CH, Wagner G (Hrsg) (1997) TNM-Klassifikation maligner Tumoren. Springer, Berlin Heidelberg New York Tokyo
23. WHO (1999) Histological typing of lung and pleural tumours. Springer, Berlin Heidelberg New York Tokyo
24. WHO (2004) Tumors of the lung, pleura, thymus and heart. IARC, Lyon
25. Yoshimi I, Ohshima A, Ajiki W et al. (2003) A comparison of trends in the incidence rate of lung cancer by histological type in the Osaka cancer registry, Japan and in the surveillance, epidemiology and end results program, USA. Jpn J Clin Oncol 33:98-194